International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease
International Stem Cell Corporation and Rohto Pharmaceutical Enter Second Stage of Research Agreement
RecycLiCo’s U.S. Subsidiary and Alaska Energy Metals Corporation Enter Memorandum of Understanding to Advance Goal of Creating Domestic Critical Metal Supply Chain
